Maximus, Inc. (NYSE:MMS) Forecasted to Post Q1 2025 Earnings of $1.39 Per Share

Maximus, Inc. (NYSE:MMS) – Analysts at Zacks Research decreased their Q1 2025 earnings per share (EPS) estimates for shares of Maximus in a research report issued on Tuesday, April 23rd. Zacks Research analyst R. Department now anticipates that the health services provider will post earnings per share of $1.39 for the quarter, down from their prior estimate of $1.40. The consensus estimate for Maximus’ current full-year earnings is $5.42 per share. Zacks Research also issued estimates for Maximus’ Q2 2025 earnings at $1.21 EPS, FY2025 earnings at $5.36 EPS and Q1 2026 earnings at $1.22 EPS.

Maximus (NYSE:MMS) last released its quarterly earnings results on Wednesday, February 7th. The health services provider reported $1.34 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.06. Maximus had a net margin of 3.73% and a return on equity of 15.68%. The business had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.29 billion. During the same quarter in the previous year, the business posted $0.94 earnings per share. The firm’s revenue for the quarter was up 6.2% compared to the same quarter last year.

A number of other research firms also recently weighed in on MMS. StockNews.com upgraded Maximus from a “hold” rating to a “buy” rating in a report on Thursday, February 8th. Raymond James downgraded Maximus from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 3rd.

Maximus Price Performance

Shares of NYSE MMS opened at $80.43 on Thursday. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.69 and a quick ratio of 1.69. Maximus has a 1 year low of $72.39 and a 1 year high of $89.69. The company’s 50-day moving average is $82.51 and its 200 day moving average is $81.29. The stock has a market capitalization of $4.91 billion, a P/E ratio of 26.63 and a beta of 0.72.

Institutional Trading of Maximus

Several institutional investors have recently bought and sold shares of the company. Mesirow Financial Investment Management Inc. purchased a new stake in Maximus during the 1st quarter valued at $483,000. Verdence Capital Advisors LLC boosted its position in shares of Maximus by 3.7% during the first quarter. Verdence Capital Advisors LLC now owns 4,730 shares of the health services provider’s stock valued at $397,000 after buying an additional 167 shares during the last quarter. New York State Teachers Retirement System increased its holdings in Maximus by 8.1% in the 1st quarter. New York State Teachers Retirement System now owns 81,543 shares of the health services provider’s stock worth $6,841,000 after buying an additional 6,079 shares in the last quarter. Long Run Wealth Advisors LLC raised its position in Maximus by 4.8% in the 1st quarter. Long Run Wealth Advisors LLC now owns 35,396 shares of the health services provider’s stock worth $2,970,000 after buying an additional 1,606 shares during the last quarter. Finally, Assenagon Asset Management S.A. bought a new position in Maximus during the 1st quarter valued at about $7,774,000. 97.21% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Maximus

In related news, CFO David Mutryn sold 8,000 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $83.95, for a total transaction of $671,600.00. Following the completion of the transaction, the chief financial officer now owns 5,124 shares of the company’s stock, valued at approximately $430,159.80. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 1.40% of the company’s stock.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Tuesday, May 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.49%. Maximus’s payout ratio is 39.74%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.